// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

INVOLVING MEN AND BOYS IN FAMILY PLANNING: A CALL TO ACTION FOR WOMEN’S HEALTH PRACTITIONERS

Friday Okonofua - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

THE ABORTION PROVIDER WORKFORCE IN CANADA

Marie-Soleil Wagner - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Mifepristone

SELF-MANAGED MEDICATION ABORTION DURING THE COVID PANDEMIC IN MEXICO CITY

Alfonso G. Carrera Riva Palacio - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Mifepristone

ADDRESSING THE BARRIERS TO SAFE ABORTION AND POST-ABORTION CARE THROUGH ADVOCACY IN NIGERIA

Friday Okonofua - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

CO-PRODUCED E-LEARNING PACKAGE ON SAFE ABORTION CARE FOR HEALTHCARE WORKERS

Jayne Kavanagh - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ADDRESSING THE BARRIERS TO SAFE ABORTION AND POST-ABORTION CARE THROUGH ADVOCACY IN ZIMBABWE

Merel Krediet a - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

RADIOFREQUENCY AND LASER TREATMENT OF STRESS URINARY INCONTINENCE (SUI) AND GENITOURINARY SYNDROME OF MENOPAUSE (GSM): A SYSTEMATIC REVIEW OF OUTCOME REPORTING FOR DEVELOPMENT OF A CORE OUTCOME SET (COS)

Jemina Loganathan - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Bladder dysfunction

N/A

ASSOCIATION BETWEEN IFI16 AND BRCA1/2 GENE EXPRESSION DURING OVARIAN CARCINOGENESIS

Jasenka Mazibrada - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ovarian cancer

Interferon

DESIGN AND EVALUATION OF AN ALTERNATIVE DELIVERY FORMAT OF AN OBSTETRIC AND ANAESTHETIC TRAINING COURSE DURING THE COVID-19 PANDEMIC

Helen A. Allott - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

THE DRIVERS AND IMPLICATIONS OF CHILDBIRTH MEDICALISATION

Mehar Chawla - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

DESIGN AND PILOTING OF MATERNAL PERINATAL DEATH SURVEILLANCE AND RESPONSE (MPDSR) ACCOUNTABILITY FRAMEWORK

Charles Ameh - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

EVACUATION OF RETAINED PRODUCTS OF CONCEPTION AND SURGICAL MANAGEMENT OF MISCARRIAGE - IS ROUTINE HISTOPATHOLOGY OF THE PRODUCTS NECESSARY IN ALL CASES?

Jyoti Singh - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

PERCEPTION OF HEALTHCARE PROVIDERS OF A NEW MATERNAL NEAR MISS REVIEW IN OMAN

Jamila T. Al Abri - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

COMPARISON BETWEEN MENSTRUAL MIGRAINE AND MENSTRUAL-UNRELATED MIGRAINE IN WOMEN ATTENDING GYNAECOLOGY CLINICS

Noreena Iqbal - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Migraine

N/A

IDENTIFYING STRATEGIES TO SUPPORT GYNAECOLOGICAL CANCER PATIENTS AND CARERS DURING THE COVID-19 PANDEMIC: LEARNING FROM PATIENT - CANCER CHARITY INTERACTIONS

Meghnaa Hebbar - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gynaecological cancer

N/A

WEIGHT NEUTRAL MEDICATION FOR WOMEN COULD EVADE WEIGHT GAIN AND PROMOTE WEIGHT LOSS; A LITERATURE REVIEW

Christos Tsitlakidis - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Migraine

N/A

CIRCUMVENTING PITFALLS OF TELEMEDICINE IN BENIGN VULVAR DISORDERS

Tolu O. Adedipe - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

HOW MIGHT POLICY REFORMS AND ECONOMIC GUIDANCE ENCOURAGED BY INTERNATIONAL FINANCIAL INSTITUTIONS IMPACT MATERNAL AND CHILD HEALTH IN DEVELOPING COUNTRIES IN THE PERIOD OF 1982-2004? A CRITICAL ANALYSIS OF CASE STUDIES IN SUB-SAHARAN AFRICA

Moena Omar Maisha F. Syed - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Congenital hemidysplasia with ichthyosiform erythroderma and limb defects

N/A

METHODS AND INDICATORS TO ASSESS THE QUALITY OF CARE USING MATERNAL NEAR MISS: A SYSTEMATIC REVIEW

Jamila T. Al Abri - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ADHERENCE TO INTIMATE EXAMINATION GUIDELINES IN REPRODUCTIVE MEDICINE

Laura Catherine Fitzgerald - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved